LloydsPharmacy parent company sees profits tumble

Latest

LloydsPharmacy parent company sees profits tumble

In Latest

LloydsPharmacy’s parent company has attributed a 53 per cent year-on-year profit drop in its European division primarily to difficulties in its UK business, singling out NHS “underfunding” and falling prescription numbers as particular challenges.

McKesson’s financial report on the three months to June 30 shows that adjusted operating profits in its European Pharmaceutical Solutions business were $35m (£28.9m) over this period, compared to $74m (£61.1m) in the same period last year.

This earnings slump was “driven by the weak retail pharmacy environment in the UK,” McKesson explained.

In a July 31 conference call with investors, McKesson CEO Brian Tyler said McKesson’s “UK retail business performance” had been hit “primarily by temporary wide NHS underfunding… [and] to a lesser extent volume weakness”.

“Performance in the other European countries was not enough to fully offset these challenges,” Mr Tyler said.

"Rationalising store footprint"

Mr Tyler spoke of actions McKesson had taken “in the UK and across Europe to reposition the business for long-term profitability,” such as recruiting “new leadership” and “further rationalising our store footprint and streamlining our back office functions”.

McKesson will “continue to evaluate our cost structure” in its UK business, he said.

The company recently said that divesting around 200 LloydsPharmacy branches since late 2017 had only been “partially” effective at tackling its problems and that it was looking at “further closures of retail pharmacy stores” in Europe.

“Incrementally positive” signs

Mr Tyler said he believed underfunding issues would “improve in the second half” of the financial year. He said he was “pleased” that Category M prices would increase from August, and that “we would expect to see further upward revisions in tariff later in the year, which should make up partially for any underfunding”.

Turning to the recently announced Communtiy Pharmacy Contractual Framework, he said the five-year deal “brings a greater clarity and long-term certainty,” although certain aspects “are yet to be fully defined and could evolve”. He viewed this as “an incrementally positive development for our UK business”.

Record my learning outcomes

Latest

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Latest

Highlighting child tooth decay

Almost nine out of 10 hospital tooth extractions among children up to the age of five are due to preventable tooth decay.

1 Min Article

bookmark_icon_off
Latest

Pharmacy teams urged to make Yellow Card reports

MHRA is raising awareness about the importance of reporting suspected side effects using the Yellow Card Scheme.

1 Min Article

bookmark_icon_off
Latest

NPA funding petition nears 90k signatures after protests

Just over 89,000 people have signed an NPA petition calling on the Government to reimburse pharmacies’ Covid-related expenses.

1 Min Article

bookmark_icon_off
Latest

PDA vows to support pharmacists for coronavirus-related work

The PDA reassures pharmacists it will support them against compensation claims or action arising from their COVID-19 efforts.

 

1 Min Article

bookmark_icon_off
Latest

Over 1.7m reached by Test and Trace claims Government

The government claims over 1.7 million people have been reached through its test and trace programme.

 

1 Min Article

bookmark_icon_off
Latest

Medicines reconciliation 'prevents hospital readmission'

Medicines reconciliation could become an essential service in the 2020-21 community pharmacy contractual framework.

1 Min Article

Recommended Learning

bookmark_icon_off
Sponsored modules

Abdominal discomfort: Multi-symptom relief with Buscomint

Discover the key benefits of a product that offers multi-symptom relief from abdominal pain, cramps and bloating, plus lifestyle advice to help manage symptoms.

5 Min Module

Sponsored modules

Supporting parents of babies with feeding issues

Common feeding feeding issues, including coloc, reflux and regurgitation, and some of the ways they can be managed

10 Min Module

Sponsored modules

Dry eye consultations

Work through a customer consultation to determine the possible cause of stinging, gritty eyes and recommend an effective treatment to help ease these symptoms.

15 Min Module

bookmark_icon_off
Sponsored modules

Understanding abdominal pain, cramps and IBS

This short video explains the symptoms of irritable bowel syndrome (IBS) and how it differs from abdominal cramps to help you recommend a suitable product for your customer’s needs.

3 Min Module

bookmark_icon_off
Sponsored modules

OTC Omeprazole tablets 20mg: an opportunity for pharmacy

This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.

10 Min Module

bookmark_icon_off
Sponsored modules

Managing fever in children

Get to grips with the current guidance on managing fever in children and how antipyretics can help, and discover products you can recommend.

10 Min Module